Dipexium Pharmaceut (DPRX) Tops Q2 EPS by 2c

Dipexium Pharmaceut (NASDAQ: DPRX) reported Q2 EPS of ($0.52), $0.02 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Dipexium Pharmaceut (DPRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c